Elion Therapeutics
Latest round
- Series B
Last raised
- Jun 2024
Total raised
- $25M
Investors
- 3
About Elion Therapeutics
, formerly Sfunga Therapeutics operates as a biotechnology company focused on the treatment of life-threatening invasive fungal infections. In June 2024, Elion Therapeutics, Inc. The firm’s product line includes F001, which is a polyene antifungal designed to reduce toxicity, particularly kidney impairment in patients. Moreover, the drug SF001 provides early antifungal therapy. The company develops therapies for combating invasive fungal infections developed from cancer treatment, organ transplants, or suffering from diseases like HIV/AIDS and severe COVID-19.
Who invested in Elion Therapeutics
3 investors across 1 round
See all investors in Elion Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jun 11, 2024
Amount
$25M
Investors
Questions about Elion Therapeutics
Who invested in Elion Therapeutics?
Elion Therapeutics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Elion Therapeutics raised?
Elion Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Elion Therapeutics last raise money?
Elion Therapeutics's most recent round on record is a Series B, in Jun 2024.
What does Elion Therapeutics do?
, formerly Sfunga Therapeutics operates as a biotechnology company focused on the treatment of life-threatening invasive fungal infections.
Where is Elion Therapeutics headquartered?
Elion Therapeutics is headquartered in New York, US.
Which VCs invest in companies like Elion Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Elion Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Elion Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.